Molecular therapy to inhibit NFκB activation by transcription factor decoy oligonucleotides

This publication has 36 references indexed in Scilit:

• Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts
  Gene Therapy, 2003
• Inhibition of NFκB activation using cis-element ‘decoy’ of NFκB binding site reduces neointimal formation in porcine balloon-injured coronary artery model
  Gene Therapy, 2003
• Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia
  Gene Therapy, 2002
• Inhibitory Effects of Novel AP-1 Decoy Oligodeoxynucleotides on Vascular Smooth Muscle Cell Proliferation In Vitro and Neointimal Formation In Vivo
  Circulation Research, 2002
• Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: Results of the randomized investigation by the thoraxcenter of antisense dna using local delivery and ivus after coronary stenting (ITALICS) trial
  Journal of the American College of Cardiology, 2002
• Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kB binding site as a novel molecular strategy
  Gene Therapy, 2001
• Safety of Intracoronary Administration of c-myc Antisense Oligomers After Percutaneous Transluminal Coronary Angioplasty (PTCA)
  Antisense and Nucleic Acid Drug Development, 2001
• Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts
  Gene Therapy, 2000
• Transcription factor decoy for NFκB inhibits TNF-α-induced cytokine and adhesion molecule expression in vivo
  Gene Therapy, 2000
• Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
  Nature, 1992